| First Author | Kim D | Year | 2010 |
| Journal | J Biol Chem | Volume | 285 |
| Issue | 2 | Pages | 1147-52 |
| PubMed ID | 19897492 | Mgi Jnum | J:159958 |
| Mgi Id | MGI:4453105 | Doi | 10.1074/jbc.M109.035865 |
| Citation | Kim D, et al. (2010) Enzymatic activity is required for the in vivo functions of CARM1. J Biol Chem 285(2):1147-52 |
| abstractText | CARM1 is one of nine protein arginine methyltransferases that methylate arginine residues in proteins. CARM1 is recruited by many different transcription factors as a positive regulator. Gene targeting of CARM1 in mice has been performed, and knock-out mice, which are smaller than their wild-type littermates, die just after birth. It has been proposed that CARM1 has functions that are independent of its enzymatic activity. Indeed, CARM1 is found to interact with a number of proteins and may have a scaffolding function in this context. However, CARM1 methylates histone H3, PABP1, AIB1, and a number of splicing factors, which strongly suggests that its impact on transcription and splicing is primarily through its ability to modify these substrates. To unequivocally establish the importance of CARM1 enzymatic activity in vivo, we generated an enzyme-dead knock-in of this protein arginine methyltransferase. We determined that knock-in cells and mice have defects similar to those seen in their knock-out counterparts with respect to the time of embryo lethality, T cell development, adipocyte differentiation, and transcriptional coactivator activity. CARM1 requires its enzymatic activity for all of its known cellular functions. Thus, small molecule inhibitors of CARM1 will incapacitate all of the enzyme's cellular functions. |
